tert-Butyl 3-hydroxy-3-(1-methyl-1h-pyrazol-5-yl)pyrrolidine-1-carboxylate

Catalog No. :
ACWHTW795
CAS No. :
1375065-72-7
Molecular Formula :
C13H21N3O3
Molecular Weight :
267.33

IUPAC Name:tert-butyl 3-hydroxy-3-(1-methyl-1H-pyrazol-5-yl)pyrrolidine-1-carboxylate

tert-Butyl 3-hydroxy-3-(1-methyl-1h-pyrazol-5-yl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$933.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-hydroxy-3-(1-methyl-1h-pyrazol-5-yl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-hydroxy-3-(1-methyl-1H-pyrazol-5-yl)pyrrolidine-1-carboxylate
MDL No.MFCD28976065
Molecular FormulaC13H21N3O3
Molecular Weight267.33
SMILESO=C(N1CC(C2=CC=NN2C)(O)CC1)OC(C)(C)C
InChI KeyIKYROIYWUZPKIC-UHFFFAOYSA-N
Synonymtert-butyl 3-hydroxy-3-(1-methyl-1H-pyrazol-5-yl)pyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 3-hydroxy-3-(1-methyl-1H-pyrazol-5-yl)-, 1,1-dimethylethyl ester
CAS No.1375065-72-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWHTW795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLYCI973 route compound structure diagram
    ACLYCI973847818-74-0 In Stock
  4. Then
  5. ACWHTW795 route product structure diagram
    ACWHTW7951375065-72-7
Inquiry

2. ACWHTW795 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWHTW795 route product structure diagram
    ACWHTW7951375065-72-7
Inquiry

Comments (0)